A change in the paradigm of antibiotic management in infective endocarditis: are we ready?

Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review

(2023) T. Fazili et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study

(2023) Mia Marie Pries-Heje et al.   EUROPEAN HEART JOURNAL

Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial

(2022) Mia M. Pries-Heje et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

(2022) Juan M Pericàs et al.   Open Forum Infectious Diseases

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

(2019) Gilbert Habib et al.   EUROPEAN HEART JOURNAL

Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna

(2018) Selma Tobudic et al.   CLINICAL INFECTIOUS DISEASES

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

(2018) Kasper Iversen et al.   NEW ENGLAND JOURNAL OF MEDICINE

2015 ESC Guidelines for the management of infective endocarditis

(2015) Gilbert Habib et al.   EUROPEAN HEART JOURNAL

Global Burden of Cardiovascular Disease

(2014) Valentin Fuster   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY